Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $106 - $127
1 Added 0.02%
4,215 $503,000
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $57,334 - $67,165
623 Added 17.35%
4,214 $448,000
Q2 2022

Aug 15, 2022

BUY
$75.79 - $100.07 $272,161 - $359,351
3,591 New
3,591 $350,000
Q4 2021

Feb 15, 2022

SELL
$79.65 - $106.22 $280,527 - $374,106
-3,522 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $23,354 - $26,837
-271 Reduced 7.14%
3,522 $338,000
Q2 2021

Aug 16, 2021

BUY
$89.43 - $102.27 $22,357 - $25,567
250 Added 7.06%
3,793 $369,000
Q1 2021

May 14, 2021

SELL
$87.57 - $119.4 $105,171 - $143,399
-1,201 Reduced 25.32%
3,543 $345,000
Q4 2020

Feb 12, 2021

BUY
$86.91 - $108.33 $114,981 - $143,320
1,323 Added 38.67%
4,744 $455,000
Q3 2020

Nov 13, 2020

SELL
$96.16 - $135.15 $56,926 - $80,008
-592 Reduced 14.75%
3,421 $329,000
Q2 2020

Aug 13, 2020

SELL
$85.09 - $130.36 $14,635 - $22,421
-172 Reduced 4.11%
4,013 $490,000
Q1 2020

May 15, 2020

SELL
$75.11 - $113.76 $660,968 - $1 Million
-8,800 Reduced 67.77%
4,185 $362,000
Q3 2019

Nov 14, 2019

BUY
$83.82 - $101.5 $17,602 - $21,315
210 Added 1.64%
12,985 $1.17 Million
Q2 2019

Aug 14, 2019

BUY
$72.24 - $91.27 $922,865 - $1.17 Million
12,775 New
12,775 $1.08 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.